FILE PHOTO: Intravenous bags hang above young cancer patients at Rady's Children Hospital as they participate in decorating golden capes to wear as superheroes as part of Childhood Cancer Month in San Diego, CaliforniaGilead Sciences could be justified in charging up to $4,500 per coronavirus patient for its drug, a nonprofit pricing watchdog saidThe California biotech is the maker of remdesivir, an experimental antiviral treatment that helped hospitalized COVID-19 patientsThe company has...
The Institute for Clinical and Economic Review is a Boston-based nonprofit that analyzes drug pricing. The pharma industry regularly clashes with ICER, criticizing its models for being too rigid. The group often finds drugs to be overpriced compared to their value in the healthcare system. a price of up to $4,500 per treatment course is justified for remdesivir. The organization cautioned its findings are based on preliminary data that may change over time.
But the California biotech has called it too early to set a long-term pricing strategy. So far, the company pledged to donate its current supply of remdesivir, which amounts to 140,000 treatment courses. The pricing question has become a top uncertainty among many investors and Wall Street analysts.
$ 50 if you take favipiravir
Couldn't expect any less hopefully the prices will grow after it proves it's effectiveness...sad how the big meds only see profit through deaths
TarikDB15
what's going on, why can't I read? It redirects to Are you sure your website is not hacked?
It didnt work on mouse model check their Feb 2018 article now they get to test for free on human.
What will this do for the stock price?
4500 for a drug that just lessens the time of being sick. This would be like having to pay 200 for tamiflu.
Wuxi AppTech in Wuhan, (also a Soros co) & Wuhan Inst. of Virology look to produce Remdesivir in arrangements with Gilead. Separately UNITAID consortium Gates, Gilead and Soros, to supply to Africa. Gilead looking to set up production in NJ but highly likely it will fail us.
Capitalism at its best!
Donated it all
$4,500 per patient and it is only for emergency....😳😳
For something that doesn't stop the transfer of Covid 19 nor does it act as a vaccine. It claims that it reduces the time you take to get over the virus. Drug company trying to make in a 'big killing'.
for all that $4.500 each person could have lots of healthy immune boosting FOOD! and still have a lot of cash left over to help others feed HEALTHY! Enough of promotion of medecine They can keep it!! Let's follow the money and the start of this coronavirus ....
As long as it works. The company is in a mess.
and it doesn't even work.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »